ClinVar Genomic variation as it relates to human health
NM_000083.3(CLCN1):c.1238T>G (p.Phe413Cys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000083.3(CLCN1):c.1238T>G (p.Phe413Cys)
Variation ID: 17531 Accession: VCV000017531.59
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 7q34 7: 143332490 (GRCh38) [ NCBI UCSC ] 7: 143029583 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Oct 20, 2024 Jul 2, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000083.3:c.1238T>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000074.3:p.Phe413Cys missense NR_046453.2:n.1343T>G non-coding transcript variant NC_000007.14:g.143332490T>G NC_000007.13:g.143029583T>G NG_009815.2:g.21365T>G P35523:p.Phe413Cys - Protein change
- F413C
- Other names
- -
- Canonical SPDI
- NC_000007.14:143332489:T:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00011
The Genome Aggregation Database (gnomAD) 0.00028
Exome Aggregation Consortium (ExAC) 0.00032
The Genome Aggregation Database (gnomAD), exomes 0.00037
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
CLCN1 | - | - |
GRCh38 GRCh37 |
1400 | 1552 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Jul 2, 2024 | RCV000019083.33 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Oct 13, 2016 | RCV000184008.5 | |
Pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
Oct 27, 2023 | RCV000346725.43 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jan 31, 2024 | RCV000638232.10 | |
CLCN1-related disorder
|
Pathogenic (2) |
criteria provided, single submitter
|
Aug 7, 2022 | RCV002291268.5 |
Pathogenic (1) |
criteria provided, single submitter
|
Aug 18, 2020 | RCV001548747.3 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Oct 13, 2016)
|
criteria provided, single submitter
Method: research
|
Congenital myotonia, autosomal dominant form
Affected status: unknown
Allele origin:
unknown,
maternal
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
Study: CSER-HudsonAlpha
Accession: SCV000584084.1 First in ClinVar: Jul 02, 2015 Last updated: Jul 02, 2015 |
Observation 1:
Number of individuals with the variant: 1
Observation 2:
Number of individuals with the variant: 1
|
|
Pathogenic
(Jun 28, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000331890.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 2
Sex: mixed
|
|
Pathogenic
(Aug 07, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
CLCN1-related disorder
Affected status: yes
Allele origin:
germline
|
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
Accession: SCV002583812.1
First in ClinVar: Oct 22, 2022 Last updated: Oct 22, 2022 |
Comment:
PS3 PP3 PP1 PS4_Moderate PM3
|
|
Pathogenic
(Oct 27, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000329299.9
First in ClinVar: Dec 06, 2016 Last updated: Nov 25, 2023 |
Comment:
Published functional studies suggest F413C results in reduced transport of the CLCN1 protein out of the endoplasmic reticulum (PMID: 17990293); In silico analysis supports that … (more)
Published functional studies suggest F413C results in reduced transport of the CLCN1 protein out of the endoplasmic reticulum (PMID: 17990293); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 1379744, 29790872, 23739125, 10690989, 7981750, 8301644, 9040760, 7951242, 11840191, 31589614, 12390967, 33263785, 18807109, 17932099, 34790634, 32670189, 18337730, 34758253, 34529042, 8533761, 17990293, 21204798) (less)
|
|
Pathogenic
(Mar 27, 2014)
|
criteria provided, single submitter
Method: clinical testing
|
Myotonia congenita, dominant
Affected status: unknown
Allele origin:
germline
|
Courtagen Diagnostics Laboratory, Courtagen Life Sciences
Accession: SCV000236506.2
First in ClinVar: Jul 02, 2015 Last updated: Jul 02, 2015 |
|
|
Pathogenic
(Feb 28, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV001715971.1
First in ClinVar: Jun 15, 2021 Last updated: Jun 15, 2021 |
Comment:
PS3, PS4_moderate, PM3, PP1, PP3
Number of individuals with the variant: 1
|
|
Pathogenic
(Jun 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
unknown
|
Athena Diagnostics
Accession: SCV000612755.4
First in ClinVar: Dec 19, 2017 Last updated: Jan 26, 2024 |
Comment:
The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant segregates with disease in multiple families with autosomal recessive … (more)
The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant segregates with disease in multiple families with autosomal recessive myotonia congenita (PMID: 8533761, 21204798), however, it has also been reported in individuals with possible autosomal dominant myotonia congenita (PMID: 11840191, 17932099). Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant reduces protein transport from the endoplasmic reticulum (PMID: 17990293). In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic. (less)
|
|
Pathogenic
(May 18, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002017365.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Jan 31, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Congenital myotonia, autosomal recessive form
Congenital myotonia, autosomal dominant form
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000759718.8
First in ClinVar: May 28, 2018 Last updated: Feb 28, 2024 |
Comment:
This sequence change replaces phenylalanine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 413 of the CLCN1 protein … (more)
This sequence change replaces phenylalanine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 413 of the CLCN1 protein (p.Phe413Cys). This variant is present in population databases (rs121912799, gnomAD 0.2%). This missense change has been observed in individuals with autosomal recessive myotonia congenita (PMID: 1379744, 8533761, 11840191, 18337730, 23739125). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 17531). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CLCN1 function (PMID: 10690989, 17990293). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Likely pathogenic
(-)
|
criteria provided, single submitter
Method: research
|
Congenital myotonia, autosomal recessive form
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Department Of Human Genetics, Institute Of Clinical And Translational Research, Biomedical Research Center, Slovak Academy Of Sciences
Accession: SCV005038730.1
First in ClinVar: May 07, 2024 Last updated: May 07, 2024 |
Comment:
The c.1238T>G (p.(Phe413Cys)) variant was found in a heterozygous state in 1 Slovak patient with Myotonia congenita, who carried also another Likely pathogenic variant in … (more)
The c.1238T>G (p.(Phe413Cys)) variant was found in a heterozygous state in 1 Slovak patient with Myotonia congenita, who carried also another Likely pathogenic variant in heterozygous state (c.2680C>T). The c.1238T>G variant is listed as a disease-causing in the HGMD database (CM920197) and it has been published for the first time in PMID: 1379744. GnomAD Exomes Version: 4.0 indicates the frequency of f = 0.000265. (less)
Number of individuals with the variant: 1
Secondary finding: no
|
|
Pathogenic
(Aug 18, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Tip-toe gait
Affected status: yes
Allele origin:
unknown
|
Practice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice Pomarino
Accession: SCV001763566.2
First in ClinVar: Aug 07, 2021 Last updated: Jun 09, 2024 |
Comment:
Myopathy refers to diseases that affect skeletal Muscles. These diseases attack muscle fibers, making muscles weak. Inherited myopathies are often caused by inheriting an abnormal … (more)
Myopathy refers to diseases that affect skeletal Muscles. These diseases attack muscle fibers, making muscles weak. Inherited myopathies are often caused by inheriting an abnormal gene mutation from a parent that causes the disease. Symptoms of congenital myopathies usually start at birth or in early childhood, but may not appear until the teen years or even later in adulthood. Congenital myopathies are somewhat unique compared with other inherited myopathies, as weakness typically affects all muscles and is often not progressive. Symptoms are: Muscle weakness, most commonly of upper arms and shoulders and thighs, muscle cramps, stiffness and spasms, fatigue with exertion and lack of energy. Our patients all walk on tiptoe, so they show similar symptoms. When we genetically test them with our toe walking panel, we find that around 90 per cent of them have a genetic variant that explains their toe walking. These can be assigned, for example, to the area of myopathies (such as variants of the COL6A3 gene), the area of hereditary neuropathies (such as variants of the KMT2C gene) or the area of metabolic diseases (such as variants of the PYGM gene). In a smaller group of patients with almost identical symptoms, no abnormality is found in the genes of our panel, but spastic paraplegia can be detected. In another small group of our toe walkers, no abnormalities can be detected in the genes analysed in our toe walking panel, nor do they suffer from spastic paraplegia, as is also the case with healthy children. In contrast to these, however, they show a tiptoe gait. These patients suffer from infantile cerebral palsy, in which toe walking can also be observed. (less)
Clinical Features:
Lower limb pain (present) , Pes cavus (present) , limited range of motion of the upper ankle (present)
Age: 40-49 years
Sex: female
Method: Gene panel analysis
|
|
Pathogenic
(Jul 02, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Congenital myotonia, autosomal recessive form
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV005203841.1
First in ClinVar: Sep 16, 2024 Last updated: Sep 16, 2024 |
Comment:
Variant summary: CLCN1 c.1238T>G (p.Phe413Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging … (more)
Variant summary: CLCN1 c.1238T>G (p.Phe413Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00037 in 251472 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in CLCN1 causing Congenital Myotonia, Autosomal Recessive Form, allowing no conclusion about variant significance. The variant c.1238T>G has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Congenital Myotonia, Autosomal Recessive Form (e.g. Meyer-Kleine_1995, Periviita_2024). These data indicate that the variant is very likely to be associated with disease. A publication reported experimental evidence evaluating an impact on protein function, and demonstrated that the variant resulted in retention of the protein product in the endoplasmic reticulum (Papponen_2008). The following publications have been ascertained in the context of this evaluation (PMID: 8533761, 38055022, 17990293). ClinVar contains an entry for this variant (Variation ID: 17531). Based on the evidence outlined above, the variant was classified as pathogenic. (less)
|
|
Pathogenic
(May 01, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV001248207.26
First in ClinVar: May 12, 2020 Last updated: Oct 20, 2024 |
Number of individuals with the variant: 1
|
|
Pathogenic
(Nov 01, 1993)
|
no assertion criteria provided
Method: literature only
|
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000039371.2
First in ClinVar: Apr 04, 2013 Last updated: Jun 24, 2019 |
Comment on evidence:
In 3 brothers with autosomal recessive generalized myotonia congenita (Becker disease; 255700), born of consanguineous parents, Koch et al. (1992) identified a homozygous T-to-G transversion … (more)
In 3 brothers with autosomal recessive generalized myotonia congenita (Becker disease; 255700), born of consanguineous parents, Koch et al. (1992) identified a homozygous T-to-G transversion in the CLCN1 gene, resulting in a phe413-to-cys (F413C) substitution toward the end of putative membrane span D8. This residue lies in a highly conserved region of the channel protein that is predicted to form a membrane-spanning alpha helix and possibly a component of the permeation pore (George et al., 1993). Koch et al. (1993) found the F413C missense mutation in 15% of chromosomes carrying a gene for recessive myotonia congenita. (less)
|
|
Likely pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
Congenital myotonia, autosomal dominant form
Affected status: yes
Allele origin:
germline
|
Genomics England Pilot Project, Genomics England
Accession: SCV001760194.1
First in ClinVar: Jul 27, 2021 Last updated: Jul 27, 2021 |
|
|
Pathogenic
(Mar 13, 2024)
|
no assertion criteria provided
Method: clinical testing
|
CLCN1-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005363923.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
The CLCN1 c.1238T>G variant is predicted to result in the amino acid substitution p.Phe413Cys. This variant has been reported in multiple unrelated individuals with myotonia … (more)
The CLCN1 c.1238T>G variant is predicted to result in the amino acid substitution p.Phe413Cys. This variant has been reported in multiple unrelated individuals with myotonia congenita (Koch et al. 1992. PubMed ID: 1379744; Papponen et al. 2008. PubMed ID: 17990293; Suominen et al. 2008. PubMed ID: 18807109; Brugnoni et al. 2013. PubMed ID: 23739125). This variant is reported in 0.25% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. This variant is interpreted as pathogenic. (less)
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A retrospective study of accuracy and usefulness of electrophysiological exercise tests. | Periviita V | Journal of neurology | 2024 | PMID: 38055022 |
NGS-Panel Diagnosis Developed for the Differential Diagnosis of Idiopathic Toe Walking and Its Application for the Investigation of Possible Genetic Causes for the Gait Anomaly. | Pomarino D | Global medical genetics | 2023 | PMID: 37091313 |
Genomic sequencing identifies secondary findings in a cohort of parent study participants. | Thompson ML | Genetics in medicine : official journal of the American College of Medical Genetics | 2018 | PMID: 29790872 |
Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands. | Stunnenberg BC | Neuromuscular disorders : NMD | 2018 | PMID: 29606556 |
The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study. | Andersen G | Brain : a journal of neurology | 2017 | PMID: 29050397 |
Targeted Next Generation Sequencing in patients with Myotonia Congenita. | Ferradini V | Clinica chimica acta; international journal of clinical chemistry | 2017 | PMID: 28427807 |
Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children. | Al-Ghamdi F | Pediatric neurology | 2017 | PMID: 28325641 |
CLCN1 mutations in Czech patients with myotonia congenita, in silico analysis of novel and known mutations in the human dimeric skeletal muscle chloride channel. | Skálová D | PloS one | 2013 | PMID: 24349310 |
A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene. | Brugnoni R | Journal of human genetics | 2013 | PMID: 23739125 |
Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene. | Sun C | Clinical genetics | 2011 | PMID: 21204798 |
High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. | Suominen T | Journal of neurology | 2008 | PMID: 18807109 |
In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia. | Trip J | European journal of human genetics : EJHG | 2008 | PMID: 18337730 |
F413C and A531V but not R894X myotonia congenita mutations cause defective endoplasmic reticulum export of the muscle-specific chloride channel CLC-1. | Papponen H | Muscle & nerve | 2008 | PMID: 17990293 |
Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. | Fialho D | Brain : a journal of neurology | 2007 | PMID: 17932099 |
Novel CLCN1 mutations with unique clinical and electrophysiological consequences. | Wu FF | Brain : a journal of neurology | 2002 | PMID: 12390967 |
Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. | Sun C | European journal of human genetics : EJHG | 2001 | PMID: 11840191 |
Functional consequences of chloride channel gene (CLCN1) mutations causing myotonia congenita. | Zhang J | Neurology | 2000 | PMID: 10690989 |
Are you as wealthy as you should be? | Lee G | Canadian journal of gastroenterology = Journal canadien de gastroenterologie | 1999 | PMID: 10360989 |
Inheritance of three distinct muscle chloride channel gene (CLCN1) mutations in a single recessive myotonia congenita family. | Sloan Brown K | Neurology | 1997 | PMID: 9040760 |
Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia. | Meyer-Kleine C | American journal of human genetics | 1995 | PMID: 8533761 |
Evidence for genetic homogeneity in autosomal recessive generalised myotonia (Becker). | Koch MC | Journal of medical genetics | 1993 | PMID: 8301644 |
The skeletal muscle chloride channel in dominant and recessive human myotonia. | Koch MC | Science (New York, N.Y.) | 1992 | PMID: 1379744 |
George, A. L., Jr. Personal Communication. 1997. Nashville, Tenn. | - | - | - | - |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CLCN1 | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs121912799 ...
HelpRecord last updated Oct 20, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.